Details of the Drug

General Information of Drug (ID: DMS49KH)

• Drug Name: Valproic Acid
• Synonyms: VALPROIC ACID; 2-Propylpentanoic acid; 2-Propylvaleric acid; Dipropylacetic acid; Depakine; Depakene; Valproate; Ergenyl; Di-n-propylacetic acid; Mylproin

Indication

Disease Entry	ICD 11	Status	REF
Absence epilepsy	N.A.	Approved	[1]
Epilepsy	8A60-8A68	Approved	[1]
Glioblastoma	2A00	Approved	[1]
Coronavirus Disease 2019 (COVID-19)	1D6Y	Investigative	[2]
Neuroblastoma	2D11.2	Investigative	[1]

• ATC Code:
  N03AG01: Valproic Acid
  N03AG: Fatty acid derivatives
  N03A: ANTIEPILEPTICS
  N03: ANTIEPILEPTICS
  N: NERVOUS SYSTEM
  N03AG01: Valproic Acid
  N03AG: Fatty acid derivatives
  N03A: ANTIEPILEPTICS
  N03: ANTIEPILEPTICS
  N: NERVOUS SYSTEM
  N03AG01: Valproic Acid
  N03AG: Fatty acid derivatives
  N03A: ANTIEPILEPTICS
  N03: ANTIEPILEPTICS
  N: NERVOUS SYSTEM
• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C8H16O2
  Canonical SMILES: CCCC(CCC)C(=O)O
  InChI: InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)
  InChIKey: NIJJYAXOARWZEE-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 3121
  ChEBI ID: CHEMBL109
  CAS Number: 99-66-1
  TTD ID: D0KP0W
• Drug-Molecule Activity Atlas (DMA)NEW: Click to Jump to the Detailed DMA Information of This Drug
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Valproic Acid FDA Label
• [2] Immunopharmacological management of COVID-19: Potential therapeutic role of valproic acid. Med Hypotheses. 2020 May 27;143:109891.